Centira is developing a bedside system that measures the brain's dynamic physiological response, continuously and non-invasively, bringing real monitoring to the at-risk patients who today are watched only in snapshots.
Elevated intracranial pressure and impaired brain compliance can trigger secondary injury, herniation, and death. Yet clinicians often can't see it coming in time. Intracranial monitoring today is binary: invasive precision for a few, episodic guesswork for everyone else.
Direct measurement, but requires neurosurgery, an ICU bed, and specialist staff, with infection and bleeding risk. Reserved for the sickest.
Patients at real risk, where invasive monitoring is unjustified, delayed, contraindicated, or removed too early. Detected late, after deterioration already shows.
Neuro exams, CT, pupillometry, and transcranial Doppler are episodic, indirect, and operator-dependent, with no continuous, dynamic insight.
For partnership, clinical collaboration, or investment conversations, we'd be glad to connect.